Lingfei Han

956 total citations
36 papers, 724 citations indexed

About

Lingfei Han is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Lingfei Han has authored 36 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Lingfei Han's work include Cervical Cancer and HPV Research (8 papers), Immunotherapy and Immune Responses (5 papers) and Cancer-related molecular mechanisms research (5 papers). Lingfei Han is often cited by papers focused on Cervical Cancer and HPV Research (8 papers), Immunotherapy and Immune Responses (5 papers) and Cancer-related molecular mechanisms research (5 papers). Lingfei Han collaborates with scholars based in China, United States and United Kingdom. Lingfei Han's co-authors include Zuo‐Hua Feng, Guimei Zhang, Ye Yuan, Dong Li, Xiao Han, Wen-Fei Wei, Fanfei Kong, Hui Geng, Hui Zhang and Xiang‐Guang Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and The Journal of Immunology.

In The Last Decade

Lingfei Han

33 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfei Han China 16 286 269 223 170 135 36 724
Yuh-Cheng Yang Taiwan 12 141 0.5× 165 0.6× 156 0.7× 132 0.8× 50 0.4× 18 576
Lorna Rodrı́guez-Rodrı́guez United States 14 489 1.7× 78 0.3× 271 1.2× 121 0.7× 110 0.8× 39 876
Yoshiaki Maru Japan 14 257 0.9× 65 0.2× 346 1.6× 77 0.5× 131 1.0× 26 702
Xiaoyan Lou China 15 431 1.5× 105 0.4× 376 1.7× 109 0.6× 189 1.4× 29 828
Changzheng Li China 12 177 0.6× 167 0.6× 162 0.7× 77 0.5× 43 0.3× 21 554
Mahmood Bozorgmehr Iran 14 293 1.0× 345 1.3× 125 0.6× 30 0.2× 120 0.9× 42 833
Chiara Massa Germany 16 325 1.1× 379 1.4× 291 1.3× 29 0.2× 141 1.0× 42 733
Vera Simić United States 9 377 1.3× 93 0.3× 338 1.5× 169 1.0× 134 1.0× 15 899
Fang Xiong China 11 522 1.8× 706 2.6× 489 2.2× 41 0.2× 243 1.8× 12 1.2k
Harris E. McFerrin United States 14 216 0.8× 95 0.4× 118 0.5× 216 1.3× 73 0.5× 22 708

Countries citing papers authored by Lingfei Han

Since Specialization
Citations

This map shows the geographic impact of Lingfei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Han more than expected).

Fields of papers citing papers by Lingfei Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Han. The network helps show where Lingfei Han may publish in the future.

Co-authorship network of co-authors of Lingfei Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Han. A scholar is included among the top collaborators of Lingfei Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Han. Lingfei Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jie, Xiaomin Fan, Lingfei Han, et al.. (2025). Targeted Europium Chelation: A Strategy for Intervening Tumor Extracellular Matrix. Nano Letters. 25(29). 11440–11448.
2.
Hu, Haoran, Xinxin Xu, Bo Yin, et al.. (2025). Tumor cells promote immunosuppression in ovarian cancer via a positive feedback loop with MDSCs through the SAA1–IL-1β axis. Journal of Experimental & Clinical Cancer Research. 44(1). 277–277.
3.
Yang, Ying, Xingyu Wang, Yexin Hu, et al.. (2024). Rapid enrichment and SERS differentiation of various bacteria in skin interstitial fluid by 4-MPBA-AuNPs-functionalized hydrogel microneedles. Journal of Pharmaceutical Analysis. 15(3). 101152–101152. 4 indexed citations
4.
5.
Liao, Qinghong, He Huang, Siyu He, et al.. (2024). Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases. European Journal of Medicinal Chemistry. 271. 116386–116386. 6 indexed citations
6.
Han, Lingfei, Xiaoxian Huang, Bin Zhao, et al.. (2023). TGF-β1 mediates tumor immunosuppression aggravating at the late stage post-high-light-dose photodynamic therapy. Cancer Immunology Immunotherapy. 72(9). 3079–3095. 3 indexed citations
7.
Han, Lingfei, Zheng Tan, Yexin Hu, et al.. (2023). Confined Target-Triggered Hot Spots for In Situ SERS Analysis of Intranuclear Genotoxic Markers. Analytical Chemistry. 95(15). 6312–6322. 6 indexed citations
8.
Yin, Bo, et al.. (2022). Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer. Frontiers in Molecular Biosciences. 9. 769032–769032. 11 indexed citations
9.
10.
Zhao, Chunyue, et al.. (2018). Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Zhao, Jingjing, Yu Wen, Junwei Zhao, et al.. (2018). Human papillomavirus DNA, HPV L1 capsid protein and p16INK4a protein as markers to predict cervical lesion progression. Archives of Gynecology and Obstetrics. 299(1). 141–149. 16 indexed citations
12.
Wei, Wen-Fei, Lingfei Han, Dan Liu, et al.. (2017). Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis. International Journal of Gynecological Cancer. 27(8). 1587–1595. 10 indexed citations
13.
Zhao, Junwei, Fang Fang, Fanfei Kong, et al.. (2016). HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability. Journal of Experimental & Clinical Cancer Research. 35(1). 180–180. 21 indexed citations
14.
Zhang, Ting, et al.. (2016). Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24(3). 189–196. 21 indexed citations
15.
Zhu, Li, et al.. (2015). Physical Status and Variant Analysis of Human Papillomavirus 16 in Women from Shanghai. Gynecologic and Obstetric Investigation. 81(1). 61–70. 2 indexed citations
16.
He, Lina, Wen-Fei Wei, Liang Li, et al.. (2014). The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer. Gynecologic Oncology. 134(2). 419–425. 44 indexed citations
17.
Maitituoheti, Mayinuer, Yan Li, Wenwen Wang, et al.. (2011). Adeno-associated Virus-mediated Local Delivery of LIGHT Suppresses Tumorigenesis in a Murine Cervical Cancer Model. Journal of Immunotherapy. 34(8). 581–587. 5 indexed citations
18.
Kong, Fanfei, Chaoyang Sun, Lingfei Han, et al.. (2011). miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(4). 543–549. 73 indexed citations
19.
20.
Geng, Hui, Guimei Zhang, Dong Li, et al.. (2006). Soluble Form of T Cell Ig Mucin 3 Is an Inhibitory Molecule in T Cell-Mediated Immune Response. The Journal of Immunology. 176(3). 1411–1420. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuh-Cheng Yang Breakdown of academic impact, for papers by Lorna Rodrı́guez-Rodrı́guez Breakdown of academic impact, for papers by Yoshiaki Maru Breakdown of academic impact, for papers by Xiaoyan Lou Breakdown of academic impact, for papers by Changzheng Li Breakdown of academic impact, for papers by Mahmood Bozorgmehr Breakdown of academic impact, for papers by Chiara Massa Breakdown of academic impact, for papers by Vera Simić Breakdown of academic impact, for papers by Fang Xiong Breakdown of academic impact, for papers by Harris E. McFerrin
Rankless by CCL
2026